1. EachPod
EachPod
CME in Minutes: Education in Oncology & Hematology - Podcast

CME in Minutes: Education in Oncology & Hematology

 Answers in CME, 71 Broadway 2B, Suite #185 New York, NY 10006

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Oncology & Hematology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for oncologists and hematologists to cover the diagnosis, staging, treatment, follow-up, and clinical management of tumors and hematological malignancies. Earning your CME/CE credits has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.

Medicine Science Health & Fitness Life Sciences
Update frequency
every 6 days
Average duration
16 minutes
Episodes
144
Years Active
2022 - 2025
Share to:
Tanios Bekaii-Saab, MD / Kelley A. Rone, DNP, AGNP-c - Providing Holistic Care for Hand-Foot Skin Reaction to Improve Outcomes for Patients on Multikinase Inhibitor Therapy for CRC

Tanios Bekaii-Saab, MD / Kelley A. Rone, DNP, AGNP-c - Providing Holistic Care for Hand-Foot Skin Reaction to Improve Outcomes for Patients on Multikinase Inhibitor Therapy for CRC

Please visit answersincme.com/MPP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, two experts—a medical oncologist and an onc…
00:13:41  |   Tue 27 Jun 2023
Sara A. Hurvitz, MD, FACP / Miguel Martín, MD, PhD - Integrating Advances in HR+ HER2- Early Breast Cancer: A Focus on Targeted Adjuvant Regimens

Sara A. Hurvitz, MD, FACP / Miguel Martín, MD, PhD - Integrating Advances in HR+ HER2- Early Breast Cancer: A Focus on Targeted Adjuvant Regimens

Please visit answersincme.com/MHQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology discuss how to optimize…
00:15:14  |   Thu 15 Jun 2023
Axel Hauschild, MD - Advancing Outcomes in Surgically Resectable Cutaneous Squamous Cell Carcinoma: Carving New Paths Forward With Immunotherapies

Axel Hauschild, MD - Advancing Outcomes in Surgically Resectable Cutaneous Squamous Cell Carcinoma: Carving New Paths Forward With Immunotherapies

Please visit answersincme.com/KDX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses the use …
00:12:56  |   Thu 15 Jun 2023
Javier Cortés, MD / Sarah Donahue, MPH, ANP, AOCNP - Putting Patients First: Optimizing Outcomes via Collaborative Care in Pretreated Advanced Triple Negative Breast Cancer Treatment

Javier Cortés, MD / Sarah Donahue, MPH, ANP, AOCNP - Putting Patients First: Optimizing Outcomes via Collaborative Care in Pretreated Advanced Triple Negative Breast Cancer Treatment

Please visit answersincme.com/HAJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology and oncology nursing di…
00:13:31  |   Mon 12 Jun 2023
Dirk Schadendorf, MD - An Evolution in Care for Advanced Melanoma: Exploring the Clinical Implications of Approved and Emerging Anti–LAG-3/PD-1 Combinations

Dirk Schadendorf, MD - An Evolution in Care for Advanced Melanoma: Exploring the Clinical Implications of Approved and Emerging Anti–LAG-3/PD-1 Combinations

Please visit answersincme.com/ZUU860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology and oncology discu…
00:12:03  |   Thu 08 Jun 2023
Jonathan Schoenfeld, MD, MPH - Evolving the Treatment Landscape in Head and Neck Squamous Cell Carcinoma: Promoting Apoptosis With Emerging Antagonists of Inhibitors of Apoptosis Proteins

Jonathan Schoenfeld, MD, MPH - Evolving the Treatment Landscape in Head and Neck Squamous Cell Carcinoma: Promoting Apoptosis With Emerging Antagonists of Inhibitors of Apoptosis Proteins

Please visit answersincme.com/EEF860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in head and neck squamous cell ca…
00:14:00  |   Wed 31 May 2023
Joseph Mikhael, MD, MEd, FRCPC / Paul G. Richardson, MD - Window of Opportunity in Relapsed/Refractory Multiple Myeloma: Is There an Earlier Role for Cereblon (CRBN) E3 Ligase Modulators to Improve Patient Outcomes?

Joseph Mikhael, MD, MEd, FRCPC / Paul G. Richardson, MD - Window of Opportunity in Relapsed/Refractory Multiple Myeloma: Is There an Earlier Role for Cereblon (CRBN) E3 Ligase Modulators to Improve Patient Outcomes?

Please visit answersincme.com/EUY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in hematology-oncology and oncology…
00:15:53  |   Wed 31 May 2023
Suriya Jeyapalan, MD, MPH - Expert Conversations in Newly Diagnosed Glioblastoma: Discussing TTFields as a Recommended Adjuvant Therapeutic Option

Suriya Jeyapalan, MD, MPH - Expert Conversations in Newly Diagnosed Glioblastoma: Discussing TTFields as a Recommended Adjuvant Therapeutic Option

Please visit answersincme.com/NYN860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neurology discusses the clinic…
00:13:36  |   Tue 23 May 2023
John O. Mascarenhas, MD - Optimizing JAK Inhibitor Therapy for Patients With Myelofibrosis: Integrating New and Emerging Therapies Into the Current Treatment Paradigm

John O. Mascarenhas, MD - Optimizing JAK Inhibitor Therapy for Patients With Myelofibrosis: Integrating New and Emerging Therapies Into the Current Treatment Paradigm

Please visit answersincme.com/BCJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hematology discusses JAK inhib…
00:15:10  |   Thu 04 May 2023
Hussein Tawbi, MD, PhD / Laura K. Ferris, MD, PhD - Optimizing Outcomes in Advanced Melanoma Through Enhanced Collaboration: A Real-World Multidisciplinary Approach

Hussein Tawbi, MD, PhD / Laura K. Ferris, MD, PhD - Optimizing Outcomes in Advanced Melanoma Through Enhanced Collaboration: A Real-World Multidisciplinary Approach

Please visit answersincme.com/DNA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology and dermatology discuss…
00:14:33  |   Thu 04 May 2023
Sergio Giralt, MD, FACP, FASTCT - Charting a New Course in the Treatment Paradigm of Relapsed/Refractory Multiple Myeloma: The Current Snapshot of Novel CAR T-Cell Therapies

Sergio Giralt, MD, FACP, FASTCT - Charting a New Course in the Treatment Paradigm of Relapsed/Refractory Multiple Myeloma: The Current Snapshot of Novel CAR T-Cell Therapies

Please visit answersincme.com/QTQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in multiple myeloma discusses tre…
00:14:12  |   Fri 21 Apr 2023
Christine E. Jones, BMBS, PhD - A Full-Throated Appeal to Personalize Care in Advanced Gastroesophageal Junction (GEJ) and Esophageal Cancers: Where Do Immunotherapy-Based Regimens Fit In?

Christine E. Jones, BMBS, PhD - A Full-Throated Appeal to Personalize Care in Advanced Gastroesophageal Junction (GEJ) and Esophageal Cancers: Where Do Immunotherapy-Based Regimens Fit In?

Please visit answersincme.com/VKP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in medical oncology discusses pat…
00:13:56  |   Mon 10 Apr 2023
Giovanni L. Ceresoli - Advancing Care in Advanced Non–Small-Cell Lung Cancer With Combination Locoregional and Systemic Therapies

Giovanni L. Ceresoli - Advancing Care in Advanced Non–Small-Cell Lung Cancer With Combination Locoregional and Systemic Therapies

Please visit answersincme.com/ADT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in thoracic oncology discusses co…
00:14:48  |   Thu 30 Mar 2023
Reinhard Dummer, Prof. Dr. med - Making the Case for a Systemic Approach to Advanced Basal Cell Carcinoma: A Multidisciplinary Team Strategy to Optimize Long-Term Care

Reinhard Dummer, Prof. Dr. med - Making the Case for a Systemic Approach to Advanced Basal Cell Carcinoma: A Multidisciplinary Team Strategy to Optimize Long-Term Care

Please visit answersincme.com/BRY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses current and…
00:14:17  |   Thu 30 Mar 2023
Ruben A. Mesa, MD, FACP - Risk-Adapted Treatment Algorithms in Myelofibrosis: Optimizing Patient Outcomes With JAK Inhibitors

Ruben A. Mesa, MD, FACP - Risk-Adapted Treatment Algorithms in Myelofibrosis: Optimizing Patient Outcomes With JAK Inhibitors

Please visit answersincme.com/AJK860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in myeloproliferative neoplasms r…
00:13:32  |   Wed 15 Feb 2023
Richard Finn, MD - Real Talk About CDK4/6 Inhibitors in the Treatment of HR+/HER2- Advanced Breast Cancer: Using Real-World Evidence to Impact Patient Outcomes

Richard Finn, MD - Real Talk About CDK4/6 Inhibitors in the Treatment of HR+/HER2- Advanced Breast Cancer: Using Real-World Evidence to Impact Patient Outcomes

Please visit answersincme.com/WWC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses the use of …
00:16:09  |   Wed 15 Feb 2023
Nicolas Girard, MD, PhD - Fortifying Outcomes in Unresectable Stage III Non–Small-Cell Lung Cancer: Current and Evolving Strategies to Optimize the Use of Consolidation Immunotherapy

Nicolas Girard, MD, PhD - Fortifying Outcomes in Unresectable Stage III Non–Small-Cell Lung Cancer: Current and Evolving Strategies to Optimize the Use of Consolidation Immunotherapy

Please visit answersincme.com/ZZB860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonology discusses availabl…
00:14:35  |   Wed 15 Feb 2023
Enriqueta Felip, MD, PhD - Breaking News for Frontline Dual Immunotherapy and Chemotherapy Combination Regimens: Improving Patient Outcomes in Advanced NSCLC

Enriqueta Felip, MD, PhD - Breaking News for Frontline Dual Immunotherapy and Chemotherapy Combination Regimens: Improving Patient Outcomes in Advanced NSCLC

Please visit answersincme.com/BTC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses recent clin…
00:15:06  |   Mon 09 Jan 2023
Omid Hamid, MD - An Expert Conversation About Anti-LAG-3/PD-1 Combinations: Exploring the Clinical Impact of Approved and Emerging Combinations in the Advanced Melanoma Treatment Landscape

Omid Hamid, MD - An Expert Conversation About Anti-LAG-3/PD-1 Combinations: Exploring the Clinical Impact of Approved and Emerging Combinations in the Advanced Melanoma Treatment Landscape

Please visit answersincme.com/GDX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology discuss the clinical im…
00:13:38  |   Tue 20 Dec 2022
Todd Schlesinger, MD, FAAD - Optimizing Immunotherapy in Patients With Advanced Basal Cell Carcinoma: Practical Strategies to Inform Care

Todd Schlesinger, MD, FAAD - Optimizing Immunotherapy in Patients With Advanced Basal Cell Carcinoma: Practical Strategies to Inform Care

Please visit answersincme.com/WZE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses strategi…
00:13:44  |   Tue 13 Dec 2022
Disclaimer: The podcast and artwork embedded on this page are the property of Answers in CME, 71 Broadway 2B, Suite #185 New York, NY 10006. This content is not affiliated with or endorsed by eachpod.com.